Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
The new Apple Watch Series 6. Photo: Apple
The newest version of the Apple Watch is part of a slew of devices that enable people to monitor their health away from a doctor's office.
Why it matters: The COVID-19 pandemic has accelerated a shift to health monitoring in the home, and companies are rushing to meet the demand.
What's happening: Apple on Tuesday announced its Watch Series 6, with a focus on the device's health capabilities.
- Already able to detect heart rate, perform an electrocardiogram and track physical activity, the new version can now determine blood oxygen levels through LED clusters and photodiodes.
- Blood oxygen saturation can be a useful indicator of health, especially during the pandemic. Many severe cases of COVID-19 are marked by alarmingly low blood oxygen levels, even before patients begin experiencing respiratory distress.
Details: The new Apple Watch is one of many remote health monitoring devices being rolled out by tech and health companies alike.
- The change is being driven by more accurate devices as well as a shift in patients themselves, who increasingly want to optimize wellness, not just avoid illness.
- "This is a golden moment for distributed medicine and at-home diagnostics," says Siddarth Satish, the CEO of Gauss, a machine-vision startup that developed the first completely at-home COVID-19 test with the biotech company Cellex.
Yes, but: It's still not clear exactly how many of these devices "ultimately fit into a user’s care continuum," notes Erin Brodwin in STAT News.
- And while monitoring your blood oxygen level on an Apple Watch looks cool, for most people the data won't be that useful on its own.
Go deeper: Apple just significantly deepened its bet on services